Expert Perspective
5m Read
December 03, 2024
COMMUNITY AND GLOBAL HEALTH
prod:prod_dcx-login
The Need
- Measurement of blood plasma HCV RNA using PCR is established as the standard of care in assessing HCV treatment and prognosis.
- Highly-sensitive tests are required to ensure sustained virologic response (SVR), defined as undetectable HCV RNA following treatment.
- HCV testing that provides accurate results are simple to use and test volume flexibility can enhance HCV elimination programs.
The Solution
- The Xpert HCV Viral Load test is designed for the rapid quantitation of Hepatitis C Virus (HCV) RNA in human serum or plasma (EDTA) from HCV-infected individuals.
- The Xpert HCV Viral Load test is intended to aid in the management of HCV infected patients undergoing antiviral therapy and can be utilized to predict sustained virological responses to HCV therapy as well as confirmation of HCV infection in anti-HCV positive individuals.
The Impact
- Increase Efficiency: Simplified workflow and on-demand testing reduces hands-on time1
- Improve Patient Care: Fast results enable earlier adjustment to appropriate therapy2,3
- Enable testing in a range of laboratory settings. Flexible: Adaptable to meeting throughput requirements4
1 McHugh et al. Multicenter Evaluation of the Cepheid Xpert Hepatitis C Virus Viral Load Assay. J Clin Microbiol. 2017 May; 55(5):1550-1556. https://www.ncbi.nlm.nih.gov/pubmed/28275079
2 Shilton et al 2022, Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective threearm study. Liver Int. 2022 Apr; 42(4): 775–786
3 Thedja et al 2021, Improving Linkage to Care of Hepatitis C: Clinical Validation of GeneXpert® HCV Viral Load Point-of-Care Assay in Indonesia Am. J. Trop. Med. Hyg., 105(1), 2021, pp. 117–124
4 Gupta et al. Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection. J Clin Virol. 2017 Mar; 88:46-51.
2 Shilton et al 2022, Feasibility and effectiveness of HCV viraemia testing at harm reduction sites in Georgia: A prospective threearm study. Liver Int. 2022 Apr; 42(4): 775–786
3 Thedja et al 2021, Improving Linkage to Care of Hepatitis C: Clinical Validation of GeneXpert® HCV Viral Load Point-of-Care Assay in Indonesia Am. J. Trop. Med. Hyg., 105(1), 2021, pp. 117–124
4 Gupta et al. Point -of -care testing (POCT) in molecular diagnostics: Performance evaluation of GeneXpert HCV RNA test in diagnosing and monitoring of HCV infection. J Clin Virol. 2017 Mar; 88:46-51.
